Second Oral Antibiotic for Gonorrhea Gets FDA Green Light
(MedPage Today) — The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication.
Zoliflodacin is the first of a new class of antibiotics…
Want to go deeper? Ask Sophie 🤔
Have a question about what you just read? Type below or click a suggestion, and Sophie will continue the conversation.
Share this Post
More Posts
Vaccines Are Helping Older People More Than We Knew
(MedPage Today) — Let’s be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, one that can…
Vaccines Are Helping Older People More Than We Knew
(MedPage Today) — Let’s be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, one that can…
Vaccines Are Helping Older People More Than We Knew
(MedPage Today) — Let’s be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, one that can…
